Springer Seminars in Immunopathology

, Volume 21, Issue 2, pp 179–190 | Cite as

Immunosuppression in uveitis therapy

  • R. N. Van Gelder
  • H. J. Kaplan
Article

Keywords

Internal Medicine Uveitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Akduman L, Kolker A, Black D, Del Priore L, Kaplan H (1996) Treatment of persistent glaucoma secondary to periocular steroids. Am J Ophthalmol 122:275Google Scholar
  2. 2.
    Aoki K, Sugiura S (1976) Immunosuppressive treatment of Behcet's disease. Mod Probl Ophthalmol 16:309Google Scholar
  3. 3.
    Atmaca LS, Batioglu F (1994) The efficacy of cyclosporin-a in the treatment of Behcet's disease. Ophthalmic Surg 25:321Google Scholar
  4. 4.
    Beaufils H, deGroc F, Gubler MC, Wechsler B, Le Hoang P, Baumelou A, Chomette G, Jacobs C (1990) Hemolytic uremic syndrome in patients with Behcet's disease treated with cyclosporin A: report of two cases. Clin Nephrol 34:157Google Scholar
  5. 5.
    Becker B (1963) Corticosteroids and intraocular pressure. Arch Ophthalmol 70:500Google Scholar
  6. 6.
    Buckley CE, Gills JP (1969) Cyclophosphamide therapy of peripheral uveitis. Arch Intent Med 124:29Google Scholar
  7. 7.
    Connell WR, Kamm MA, Dickson M (1994) Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 343:1249Google Scholar
  8. 8.
    Fauci A, Haynes B, Katz P, Wolff S (1983) Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients. Ann Intern Med 98:76Google Scholar
  9. 9.
    Fauci AS (1978) Clinical aspects of immunosuppression: use of cytotoxic agents and corticosteroids. In: Belland JA (ed) Immunology. Saunders, Philadelphia, pp 740–747Google Scholar
  10. 10.
    Fraunfelder F, Meyer S (1983) Ocular toxicity of antineoplastic agents. Ophthalmology 90:1Google Scholar
  11. 11.
    Godfrey WA, Epstein WV, O'Conner GR (1974) The use of chlorambucil in intractable idiopathic uveitis. Am J Ophthalmol 78:415Google Scholar
  12. 12.
    Hemady R, Tauber J, Foster C (1991) Immunosuppressive drugs in immune and inflammatory ocular disease. Surv Ophthalmol 35:369Google Scholar
  13. 13.
    Hench PS, Kendall EC, Slocumb CH, Polley HF (1949) The effect of a hormone of the adrenal cortex (17-hydroxyl-11-dehydrocortisone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 24:181Google Scholar
  14. 14.
    Hooper PL, Kaplan HJ (1991) Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology 98:944Google Scholar
  15. 15.
    Jaffe GJ, Yang C-S, Want X-C, Cousins SW, Gallemore RP, Ashton P (1998) Intravitreal sustained-release cyclosporin in the treatment of experimenal uveitis. Ophthalmology 105:46Google Scholar
  16. 16.
    Kende G, Sirkin SR, Thomas PRM (1979) Blurring of vision: a previously undescribed complication of cyclophosphamide therapy. Cancer 44:69Google Scholar
  17. 17.
    Leibowitz H, Bartlett J, Rich R, McQuirter H, Stewart R, Assil K (1996) Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids. Arch Ophthalmol 114:933Google Scholar
  18. 18.
    Mamo JG, Azzam SA (1970) Treatment of Behcet's disease with chlorambucil. Arch Ophthalmol 84:446Google Scholar
  19. 19.
    Martin DF, DeBarge LR, Nussenblatt RB, Chan CC, Roberge FG (1995) Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis. J Immunol 154:922Google Scholar
  20. 20.
    Mochizuki M, Masuda K, Sakane T (1993) A clinical trial of FK506 in refractory uveitis. Am J Ophthalmol 115:763Google Scholar
  21. 21.
    Monteiro L, Almeida-Pinto J, Rocha N, Lopes G, Rocha J (1993) Case report: cyclosporin A-induced neurotoxicity. Br Radiol 66:271Google Scholar
  22. 22.
    Newell FW, Krill AE, Thomson A (1966) The treatment of uveitis with 6-mercaptopurine. Am J Ophthalmol 61:1250Google Scholar
  23. 23.
    Nussenblatt RB, Palestine AG (1986) Cyclosporine: immunology, pharmacology, and therapeutic uses. Surv Ophthalmol 31:159Google Scholar
  24. 24.
    Nussenblatt RB, Caspi RR, Mahdi R (1990) Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 144:1689Google Scholar
  25. 25.
    Nussenblatt RB, Whitcup SM, Palestine AG (1996) Uveitis, 2nd edn. Mosby, St. LouisGoogle Scholar
  26. 26.
    Ozyazgan Y, Yurdakul S, Yazici H, Tuzun B, Iscimen A, Tuzun Y, Aktunc T, Pazarli H, Hamuryudan V, Muftuoglu A (1992) Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial. Br Ophthalmol 76:241Google Scholar
  27. 27.
    Pacor ML, Biasi D, Lunardi C, Cortina P, Caramaschi P, Girelli D, Botto M, Urbani G, Lombardo G, Bambara LM (1994) Cyclosporin in Behcet's disease: results in 16 patients after 24 months of therapy. Clin Rheumatol 13:224Google Scholar
  28. 28.
    Rocha G, Deschenes J, Cantarovich M (1997) Cyclosporin monitoring with levels 6 hours after the morning dose in patients with noninfectious uveitis. Ophthalmology 104:245Google Scholar
  29. 29.
    Rosenbaum JT (1994) Treatment of severe refractory uveitis with intravenous cyclophosphamide. J Rheumatol 21:123Google Scholar
  30. 30.
    Shah SS, Lowder CY, Scmitt MA (1992) Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 99:1419Google Scholar
  31. 31.
    Somerville AF, Scott TG (1997) Neoral - new cyclosporin for old? Br J Rheumatol 36:1113Google Scholar
  32. 32.
    Tessler HH, Jennings T (1990) High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behcet's disease. Br J Ophthalmol 74:353Google Scholar
  33. 33.
    Trentham DE, Dynesius-Trentham RA, Orav EJ (1993) Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727Google Scholar
  34. 34.
    Vitale AT, Rodriguez A, Foster CS (1996) Low-dose cyclosporin A therapy in treating chronic, non-infectious uveitis. Ophthalmology 103:365Google Scholar
  35. 35.
    Wakefield D, McCluskey P (1991) Cyclosporin: a therapy in inflammatory eye disease. J Ocul Pharmacol 7:221Google Scholar
  36. 36.
    Weiner HL, Mackin GA, Matsui (1993) Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321Google Scholar
  37. 37.
    Wong VG (1969) Immunosuppressive therapy of ocular inflammatory diseases. Arch Ophthalmol 81:628Google Scholar
  38. 38.
    Zhao Z-S, Granucci F, Yeh L, Schaffer P, Cantor H (1998) Molecular mimicry of herpes-simplex type I: autoimmune disease after viral infection. Science 279:1344Google Scholar

Copyright information

© Springer-Verlag 1999

Authors and Affiliations

  • R. N. Van Gelder
    • 1
  • H. J. Kaplan
    • 1
  1. 1.Department of Ophthalmology and Visual SciencesWashington University Medical SchoolSt. LouisUSA

Personalised recommendations